Fulvestrant as First-Line Treatment for Advanced Breast CancerByJohn F. R. Robertson, MDDecember 12th 2014John F. R. Robertson, MD, discusses overall survival data from the phase II FIRST study, which looked at fulvestrant as first-line therapy for patients with advanced breast cancer.